Lifestyle factors and comorbidities in gout patients compared to the general population in Western Sweden: results from a questionnaire study
暂无分享,去创建一个
[1] L. Jacobsson,et al. The Validity of Gout Diagnosis in Primary Care: Results from a Patient Survey , 2019, The Journal of Rheumatology.
[2] P. Nilsson,et al. The risk of clinically diagnosed gout by serum urate levels: results from 30 years follow-up of the Malmö Preventive Project cohort in southern Sweden , 2018, Arthritis Research & Therapy.
[3] L. Jacobsson,et al. Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapy , 2018, Arthritis Research & Therapy.
[4] T. Merriman,et al. An association of smoking with serum urate and gout: A health paradox. , 2017, Seminars in arthritis and rheumatism.
[5] A. Astrup,et al. Weight loss for overweight and obese individuals with gout: a systematic review of longitudinal studies , 2017, Annals of the rheumatic diseases.
[6] M. Petzold,et al. Factors associated with initiation and persistence of urate-lowering therapy , 2017, Arthritis Research & Therapy.
[7] P. Restani,et al. Drinking pattern of wine and effects on human health: why should we drink moderately and with meals? , 2016, Food & function.
[8] L. Jacobsson,et al. Validity of gout diagnosis in Swedish primary and secondary care - a validation study , 2015, BMC Musculoskeletal Disorders.
[9] F. Becce,et al. 2016 updated EULAR evidence-based recommendations for the management of gout , 2014, Annals of the rheumatic diseases.
[10] D. Hunter,et al. Alcohol quantity and type on risk of recurrent gout attacks: an internet-based case-crossover study. , 2014, The American journal of medicine.
[11] Hyon K. Choi,et al. Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007-2008. , 2012, The American journal of medicine.
[12] R. Glynn,et al. Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. , 1987, The American journal of medicine.